Royalty Pharma Appoints Carole Ho and Bess Weatherman to Board
Investor - People | Jul 17, 2025 | RP Management LLC
Royalty Pharma plc, a prominent biopharmaceutical royalties acquirer, has announced the appointment of Carole Ho and Elizabeth Weatherman to its Board of Directors. This decision is part of the company’s strategic move to enhance corporate governance and promote growth, as reflected by an over 90% representation of independent members on its board. Carole Ho, who brings 20 years of biopharmaceutical experience, currently serves as Chief Medical Officer at Denali Therapeutics and has been involved in various stages of drug development. Elizabeth Weatherman, with 35 years in healthcare investing, has been a pivotal member of Warburg Pincus LLC. Their combined expertise in biopharma and finance is set to drive forward Royalty Pharma's long-term strategies. The firm's mission includes funding biopharmaceutical innovations, partnering in late-stage clinical trials, and maintaining a portfolio of royalties in leading therapies, underscoring its commitment to innovation.
Sectors
- Biopharmaceutical
- Corporate Governance
Geography
- United States – The article primarily revolves around Royalty Pharma, a New York-based company, and its leadership changes impacting its corporate structure in the U.S.
Industry
- Biopharmaceutical – Royalty Pharma operates in the biopharmaceutical industry as it acquires royalties on biopharmaceutical products and funds related innovations.
- Corporate Governance – The article discusses enhancements to Royalty Pharma’s board of directors, focusing on independent representation and leadership, which directly relates to corporate governance.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Royalty Pharma plc | Target Company | Company | A leading firm in acquiring biopharmaceutical royalties and funding innovations within the industry. |
| Carole Ho | Board Member | Person | Chief Medical Officer at Denali Therapeutics, recognized for her experience in drug development within the biopharmaceutical sector. |
| Elizabeth Weatherman | Board Member | Person | A Special Limited Partner at Warburg Pincus with extensive experience in healthcare investing. |
| RP Management LLC | Private Equity | Company | Oversees management changes at Royalty Pharma. |
| Warburg Pincus LLC | Industry Peer/Investor | Company | A global private equity firm with investment interests in the healthcare sector. |